Evidence map›Paper›PMID 42402043›Full record

ArticleVirulence2026

Identification and profiling of HLA-A*02:01-restricted

Ruiying Liang, Xinru Luo, Weixiang Xia, Haotian Gu, Dan Li, Yongyu Gao, Zonghui Zuo, Fengshan Gao, Jiabo Ding, Xinming Tang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Virulence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ruiying LiangThe Dalian Animal Virus Antigen Epitope Screening and Protein Engineering Drug Developing Key Laboratory, Dalian, China; Department of Bioengineering, College of Life and Health, Dalian University, Dalian, Liaoning, China.
Xinru LuoKey Laboratory of Animal Biosafety Risk Prevention and Control (North) and Key Laboratory of Veterinary Biological Products and Chemical Drugs of Ministry of Agriculture and Rural Affairs (MARA), Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Weixiang XiaThe Dalian Animal Virus Antigen Epitope Screening and Protein Engineering Drug Developing Key Laboratory, Dalian, China; Department of Bioengineering, College of Life and Health, Dalian University, Dalian, Liaoning, China.
Haotian GuKey Laboratory of Animal Biosafety Risk Prevention and Control (North) and Key Laboratory of Veterinary Biological Products and Chemical Drugs of Ministry of Agriculture and Rural Affairs (MARA), Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Dan LiThe Dalian Animal Virus Antigen Epitope Screening and Protein Engineering Drug Developing Key Laboratory, Dalian, China; Department of Bioengineering, College of Life and Health, Dalian University, Dalian, Liaoning, China.
Yongyu GaoThe Dalian Animal Virus Antigen Epitope Screening and Protein Engineering Drug Developing Key Laboratory, Dalian, China; Department of Bioengineering, College of Life and Health, Dalian University, Dalian, Liaoning, China.
Zonghui ZuoCollege of Animal Science and Veterinary Medicine, Tianjin Agricultural University, Tianjin, China.ORCID 0000-0002-3582-2210
Fengshan GaoThe Dalian Animal Virus Antigen Epitope Screening and Protein Engineering Drug Developing Key Laboratory, Dalian, China; Department of Bioengineering, College of Life and Health, Dalian University, Dalian, Liaoning, China.ORCID 0000-0003-1646-5227
Jiabo DingKey Laboratory of Animal Biosafety Risk Prevention and Control (North) and Key Laboratory of Veterinary Biological Products and Chemical Drugs of Ministry of Agriculture and Rural Affairs (MARA), Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.
Xinming TangKey Laboratory of Animal Biosafety Risk Prevention and Control (North) and Key Laboratory of Veterinary Biological Products and Chemical Drugs of Ministry of Agriculture and Rural Affairs (MARA), Institute of Animal Sciences, Chinese Academy of Agricultural Sciences, Beijing, China.ORCID 0000-0003-0127-1235
Zibin LiThe Dalian Animal Virus Antigen Epitope Screening and Protein Engineering Drug Developing Key Laboratory, Dalian, China; Department of Bioengineering, College of Life and Health, Dalian University, Dalian, Liaoning, China.ORCID 0000-0001-7291-0423

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HLA class I presentation of pathogen-derived peptides is essential for CD8+ T-cell recognition of

Indexed as

Antigens, ProtozoanHLA-A2 AntigenPeptidesToxoplasmaAnimalsCD8-Positive T-LymphocytesHumansLigandsMiceMice, TransgenicProteomicsToxoplasmosisAntigens, ProtozoanHLA-A*02:01 antigenHLA-A2 AntigenLigandsPeptidescrystal structureepitopeHLA-A2.1 transgenic miceimmunopeptidomicsToxoplasma gondii

Identifiers

PMID42402043
PMCPMC13348963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.